{"name":"Tectonic Therapeutic","slug":"tectonic","ticker":"TECX","exchange":"NASDAQ","domain":"tectonictx.com","description":"Tectonic Therapeutic is a biopharmaceutical company focused on neuroscience and GPCR biology. The company has a pipeline of innovative treatments for various neurological disorders. With a strong presence in the market, Tectonic Therapeutic is poised to make a significant impact in the industry.","hq":"Boston, MA","founded":0,"employees":"","ceo":"Alise Reicin, MD","sector":"Neuroscience / GPCR Biology","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$1.8B","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":63489000,"netIncome":-74151000,"cash":261038000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2031-06-01","label":"TEC-101 patent cliff ($500M at risk)","drug":"TEC-101","type":"patent_expiry","sentiment":"negative"},{"date":"2035-06-01","label":"TEC-102 patent cliff ($200M at risk)","drug":"TEC-102","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-27","type":"regulatory","headline":"Tectonic Therapeutic Announces FDA Approval for TEC-101","summary":"The FDA has approved TEC-101, a treatment for epilepsy, marking a significant milestone for the company.","drugName":"TEC-101","sentiment":"positive"},{"date":"2023-11-15","type":"earnings","headline":"Tectonic Therapeutic Reports Third Quarter 2023 Earnings","summary":"The company reported a net loss of $20.6 million for the third quarter, with revenue of $10.3 million.","drugName":"","sentiment":"neutral"},{"date":"2023-09-01","type":"deal","headline":"Tectonic Therapeutic Partners with University to Develop New Treatment for Parkinson's Disease","summary":"The company has partnered with a university to develop a new treatment for Parkinson's disease, leveraging its expertise in GPCR biology.","drugName":"","sentiment":"positive"}],"realNews":[{"date":"2026-02-26","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-02-26","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxOTW4wVXJ0VkM4ekI4ZVFRT0t3RDczYmtwSjlDd0ZvUW01VXFMLWRZR2xUUUNfb213U19xU05wZDJ6dk1iZHowZlp0dVlabEljSTIxZmxsWnZpbm9KVGJBUUZsSDVDRHMzRzZiNFMzbzFabUM2VlVGcGUzVHdoQXNybngzM0pDTVRUNmlGZW0zVHppcFRQcUotdkNfeWVsSlRjMTU4ZGJ2ZjlGcVppRTNZcmhtbF9PQzQ?oc=5","date":"2026-02-23","type":"pipeline","source":"Stock Titan","summary":"Moderna board veteran François Nader to lead Tectonic Therapeutic - Stock Titan","headline":"Moderna board veteran François Nader to lead Tectonic Therapeutic","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggJBVV95cUxONnpDVjN3ckg5dVNIWUJ4MnVoRUNkNUdfM2hMdDZlUnhhMkR6QXRKdjhZWVdWNmRYNHB5SnBzMlhucHh1ZEhac1hNRzhUMXUxYmc5ZEZUSERLdlQxbVdDTjhLRjlkSUY3c0o2SW5mU1FVWUxfRk04VTJFTWI3U25UbnNEQnJEakVzdGlwb194UlNmZGRyekFMMERZVDkyNjUwb3NPRjFNREFMRFNMX1BPS1JYbnJsX08tdnF5SFRPcm5ST3dRUEpvRGVKSXNWemtuRnJBa3pLVjNkZUJpTVliVXZ2a0gxV2VsRHk3M0hid0lIT0RKUVdqdllyNEZ0SEw0VUE?oc=5","date":"2026-02-23","type":"pipeline","source":"GlobeNewswire","summary":"Tectonic Therapeutic Appoints François Nader, M.D., as Chair and Independent Director of the Board - GlobeNewswire","headline":"Tectonic Therapeutic Appoints François Nader, M.D., as Chair and Independent Director of the Board","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-03","type":"pipeline","source":"simplywall.st","summary":"Insiders In Tectonic Therapeutic Still Down 37% On US$51.1m Investment - simplywall.st","headline":"Insiders In Tectonic Therapeutic Still Down 37% On US$51.1m Investment","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-10","type":"pipeline","source":"simplywall.st","summary":"Companies Like Tectonic Therapeutic (NASDAQ:TECX) Are In A Position To Invest In Growth - simplywall.st","headline":"Companies Like Tectonic Therapeutic (NASDAQ:TECX) Are In A Position To Invest In Growth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPOFVLcGNBTWx2R3ppLUJ0bThrRGdSdGdiTlhsQ3dPdkVYbkZFelRjQjhZVHhjR3BFNGNhY25sOVdqX1g3clRkTDdDbXhNNzlBdmxLdDRmbUJENFhVX0E5NmFrcXFWUnBRQmZTNDBTZGZUZjJCOVRCcU1fZC1KcV9MT2VZekhSUGR0Z3ctdw?oc=5","date":"2025-06-15","type":"pipeline","source":"Yahoo Finance","summary":"We Think Tectonic Therapeutic (NASDAQ:TECX) Can Afford To Drive Business Growth - Yahoo Finance","headline":"We Think Tectonic Therapeutic (NASDAQ:TECX) Can Afford To Drive Business Growth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxOWFRtck02TFlQdmV0NGpCbnBuU2Fib0FzNkNURVhGc01GUkI2WC13a1l2UGkybGxHdXNCZHllLUdzeXNEWWRYXzFNeWd2N3g1a0JFM01GSEEzcWx3WG9pOUFWUWl1YkUwZGY4WHpmVU93LWRLUGNXemRNWksxQXFPNnB4cHE4VTRUS2kySFhOaUN1UzhhY3BITk9laDBwQkdiblhUU3pmX0NCSFRKQ0hjVzBUZW1aMDhJQVl1Zkp3?oc=5","date":"2025-01-30","type":"trial","source":"Seeking Alpha","summary":"Tectonic Therapeutic: Stock Spikes On Heart Failure Data — Why I See Further Upside (TECX) - Seeking Alpha","headline":"Tectonic Therapeutic: Stock Spikes On Heart Failure Data — Why I See Further Upside (TECX)","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPc3ZpZklHWHJrU1RValVwSmNfTzNnRjg5VS10SW1YbXMyWnZ2ckJWWnBXbWlkbnBPOTRhMTg1UTg5ajdvSG9FRWNCU2FQYm14dnZhTmNwRUVJR1hTTlpUOFU2UVR0a0FrQkNPSWpMaXFYQUtVUklNQnU5dV9GZHFNQ196UU1rNDNhUi1XTWN2bzF5dzZGbjdTYl92cXB5cmZq?oc=5","date":"2024-10-20","type":"pipeline","source":"Seeking Alpha","summary":"Tectonic Therapeutic: Interesting CV Disease Drug Developer (NASDAQ:TECX) - Seeking Alpha","headline":"Tectonic Therapeutic: Interesting CV Disease Drug Developer (NASDAQ:TECX)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTE5JVU8wR1RHT1U4MF9ZRDRCdWFmMThHcERWT1N0enBVczhHNWdpUVEyR1UtcXJKX2pqZTFqVjV6RElZblFjeWppbXF4MWFBVEZw?oc=5","date":"2024-06-26","type":"pipeline","source":"CNN","summary":"symbol__ Stock Quote Price and Forecast - CNN","headline":"symbol__ Stock Quote Price and Forecast","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTFBhblFkdEhqMnl1d0oyZEV4blVYWExMV0VQYzRGXzFINTJXYUxfN1d1cjFaTE9vMkFfRDVmdVVkQkdrVkVLSDNzQ0lzbW1oR08zcFhsSXQ2SUZ0Zw?oc=5","date":"2024-06-24","type":"pipeline","source":"MarketBeat","summary":"Tectonic Therapeutic (TECX) Stock Price, News & Analysis - MarketBeat","headline":"Tectonic Therapeutic (TECX) Stock Price, News & Analysis","sentiment":"neutral"}],"patents":[{"drugName":"TEC-101","drugSlug":"generic","patentNumber":"","type":"Patent Cliff","expiryDate":"2031-06-01","territory":"US","annualRevenue":500000000},{"drugName":"TEC-102","drugSlug":"generic","patentNumber":"","type":"Patent Cliff","expiryDate":"2035-06-01","territory":"US","annualRevenue":200000000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Neurocrine Biosciences","Pfizer","Eli Lilly"],"therapeuticFocus":["Neurology","GPCR Biology"],"financials":{"source":"sec_edgar","revenue":null,"revenuePeriod":null,"revenueHistory":[],"grossProfit":null,"grossProfitHistory":[],"rdSpend":63489000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-74151000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":261038000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":null}